Rifampicin in the treatment of resistant pulmonary tuberculosis.
D000328:Adult; D000368:Aged; D000995:Antitubercular Agents / Q000097:blood; D055598:Chemical Phenomena; D002621:Chemistry; D002908:Chronic Disease; D004352:Drug Resistance, Microbial; D004357:Drug Synergism; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D008875:Middle Aged; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification; D012293:Rifampin / Q000008:administration & dosage* / Q000009:adverse effects; D013183:Sputum / Q000032:analysis; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000995:Antitubercular Agents; D012293:Rifampin